The effects of risperidone vs haloperidol on cognitive functioning in treatment-resistant schizophrenia: The trail making test

CNS Spectrums

Volumn 2, Issue 8, 1997, Pages 60-64

  Mcgurk, Susan R ^a   Green, Michael F ^b   Wirshing, William C ^b,c   Ames, Donna ^d   Marshall Jr , B D ^d   Marder, Steven R ^d   Mintz, Jim ^d  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002826116     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900005058     Document Type: Review

References (13)

1. Goldberg TE, Berman KF, Weinberger DR. Neuropsychology and neurophysiology of schizophrenia. Curr Opin Psychiatry. 1995;8:34-40.
2. Saykin AJ, Schtasel DL, Gur RE, et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 1994;51:124-131.
3. Cassens G, Inglis AK, Appelbaum PS, Gutheil TG. Neuroleptics: effects on neuropsychological function in chronic schizophrenia patients. Schizophr Bull. 1990;16:477-499.
4. Spohn HE, Strauss ME. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol. 1989;98:367-380.
5. 2 antagonism in schizophrenia: clinical, extrapyramidal and neuroendocrine response in a preliminary study with risperidone. Hum Psychopharmacol. 1990;5:225-231.
6. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994;151:825-835.
7. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia. Am J Psychiatry. 1996;153:321-330.
8. Green MF, Marshall BD, Wirshing WC, et al. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry. 1997: In press.
9. Trestman RL, Keefe RS, Mitropoulou V, et al. Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. Psychiatry Res. 1995;58:127-136.
10. Fredericks RS, Finkel P. Schizophrenic performance on the Halstead-Reitan Battery. J Clin Psychol. 1978;34:26-30.
11. Simon SH. The effects of tranquilizers on the Trail Making Test with chronic schizophrenic patients. Journal of Consulting Psychology (J Consult Clin Psychcol). 1967;31:322-323.
12. Kane J, Honigfeld G, Singer J, Meltzer H, Group CCS. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
13. Altman HJ, Normile HJ. What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia: Neurobiol Aging. 1988;9:627-638.